Israel Englander Lyra Therapeutics, Inc. Transaction History

Millennium Management LLC

$224 Billion
Q1 2024

A detailed history of Israel Englander (Millennium Management LLC) transactions in Lyra Therapeutics, Inc. stock. As of the latest transaction made, Millennium Management LLC holds 406,121 shares of LYRA stock, worth $113,713. This represents 0.0% of its overall portfolio holdings.

Number of Shares

406,121

Previous 325,995 24.58%

Holding current value

$113,713

Previous $1.71 Million 47.89%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$4.55 - $6.53 $364,573 - $523,222	80,126 Added 24.58%	406,121 $2.53 Million
Q4 2023 Feb 14, 2024	BUY	$2.82 - $5.24 $919,305 - $1.71 Million	325,995 New	325,995 $1.71 Million
Q1 2023 May 15, 2023	BUY	$1.95 - $3.09 $113,279 - $179,504	58,092 New	58,092 $120,000
Q3 2022 Nov 14, 2022	SELL	$5.33 - $6.6 $372,018 - $460,660	-69,797 Reduced 78.68%	18,908 $95,000
Q2 2022 Aug 15, 2022	SELL	$4.12 - $7.51 $98,888 - $180,255	-24,002 Reduced 21.3%	88,705 $501,000

Q1 2022 May 16, 2022	SELL	$3.5 - $5.36 $140,794 - $215,616	-40,227 Reduced 26.3%	112,707 $453,000
Q4 2021 Feb 14, 2022	BUY	$4.22 - $9.41 $146,754 - $327,242	34,776 Added 29.43%	152,934 $667,000
Q3 2021 Nov 15, 2021	SELL	$6.06 - $9.43 $224,080 - $348,693	-36,977 Reduced 23.84%	118,158 $1.08 Million
Q2 2021 Aug 16, 2021	BUY	$6.91 - $12.59 $1.07 Million - $1.95 Million	155,135 New	155,135 $1.25 Million
Q1 2021 May 17, 2021	SELL	$10.38 - $15.61 $456,927 - $687,152	-44,020 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$9.28 - $13.88 $408,505 - $610,997	44,020 New	44,020 $502,000
Q3 2020 Nov 16, 2020	SELL	$10.61 - $13.96 $529,555 - $696,757	-49,911 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$10.91 - $18.56 $544,529 - $926,348	49,911 New	49,911 $566,000

Others Institutions Holding LYRA

# of Institutions

Shares Held

44.4M

Call Options Held

300K

Put Options Held

1.3K

View Full List

About Lyra Therapeutics, Inc.

Ticker LYRA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,826,400
Market Cap $8.91M
Description
Lyra Therapeutics, Inc., a clinical-stage therapeutics company, focuses on the development and commercialization of novel integrated drug and delivery solutions for the localized treatment of patients with ear, nose, and throat diseases. It's XTreo technology platform is designed to deliver medicines directly to the affected tissue for sustained...

More about LYRA

Track Israel Englander's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.

Account